Results 91 to 100 of about 39,176 (275)

Insights from a 6‐year hair drug analysis compendium in drug‐facilitated sexual assault cases

open access: yesJournal of Forensic Sciences, EarlyView.
Abstract Drug‐facilitated sexual assault (DFSA) may involve a diverse array of substances, including illicit drugs, prescription medications, and over‐the‐counter pharmaceuticals. Hair analysis has emerged as a valuable forensic tool, offering an extended window of detection spanning several months. However, interpreting drug concentrations in hair can
Amandine Fort   +8 more
wiley   +1 more source

Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in
Antti Mustonen   +7 more
wiley   +1 more source

Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction There is evidence that electroconvulsive therapy (ECT) can augment the effects of antipsychotics in schizophrenia. However, there is limited evidence from Western populations on whether ECT reduces the risk of relapse compared to non‐ECT treatment in schizophrenia.
Linnea Stenmark   +2 more
wiley   +1 more source

Clozapine-induced insulin-resistant hyperglycemia in a diabetic patient

open access: yesIndian Journal of Psychological Medicine, 2018
Clozapine is superior to all other antipsychotics in treatment-resistant schizophrenia. However, metabolic side effects are common while treating patients with clozapine.
Vijay Chathoth   +2 more
doaj   +1 more source

Clozapine in the community [PDF]

open access: yesBritish Journal of Psychiatry, 1992
M, Phelan, G, Strathdee, K, Jones
openaire   +2 more sources

Clozapine-induced pneumonitis mimicking an atypical pneumonia

open access: yes
Clozapine is an antipsychotic used for treatment-resistant schizophrenia with a significant side effect profile, including agranulocytosis, myocarditis and fever.
Jasenthu Kankanamage, Nuwan   +2 more
core   +1 more source

Off-Target Effects of Psychoactive Drugs Revealed by Genome-Wide Assays in Yeast [PDF]

open access: yes, 2008
To better understand off-target effects of widely prescribed psychoactive drugs, we performed a comprehensive series of chemogenomic screens using the budding yeast Saccharomyces cerevisiae as a model system.
Nislow, Corey   +20 more
core   +1 more source

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

open access: yesAddiction, EarlyView.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier   +3 more
wiley   +1 more source

What is the current scope of research assessing patients’ and clinicians’ perspectives on clozapine treatment? A comprehensive scoping review

open access: yesBMJ Open
Objectives Clozapine is continuously underused. The existing systematic reviews addressing barriers to clozapine prescribing primarily focus on clinical staff’s attitudes and perceived barriers to prescribing.
Jimmi Nielsen   +5 more
doaj   +1 more source

Patients' and relatives' assessment of clozapine treatment

open access: yes, 2001
Published version: http://journals.cambridge.org/action/displayJournal?jid ...
Loffler, W   +4 more
core  

Home - About - Disclaimer - Privacy